The offer register will replace the prospectus but, until there is an emergence of practice in relation to full FMCA offers, the issue of how much continuity there will be between the two forms and how much difference is not capable of a full answer
[5].
Fears are that it will become a dumping ground by fearful issuers and their advisors for anything which could be remotely conceived as material or – in the alternative – that the information on the register will be insufficiently scrutinised or organised, exposing directors and other market participants to liability for defective disclosure.
From experiences elsewhere and from the draft FMC
Regulations, it is clear that two sorts of registration requirements are contemplated - specific documents (or information that would likely be presented in the form of a document) and data required to be inputted into designated fields, to enable the register’s ‘google’ functionality.
The PDS system also relies heavily on ‘incorporation by reference’, with such things as financial statements, material contracts or descriptions of them, and independent expert reports contained on the offer register.
Ross Pennington is a partner at Chapman Tripp specialising in capital markets, banking and structured finance
[1] Refer Ministry of Business, Innovation and Employment Financial Markets Conduct Regulations: Third Exposure Draft, Commentary and request for submissions (May 2014) at paras 63, 117, 185, 221-224, and 266.
[2] See the reference to “what the issuer considers to be” in clause 10 of Schedule 2 to the FMC Regulations (equity) and clause 9 of Schedule 4 (managed investment schemes), and the discussion in MBIE’s discussion in the Commentary on the Third Exposure Draft FMC Regulations (note 1) at para 122.
[3] Refer MBIE Commentary on the Third Exposure Draft FMC Regulations (note 1) at para 38.
[4] Section 59(1) FMCA. There is also a variant to this definition in relation to Part 5 (Dealings in financial products on markets), which focuses on the impact on the price of the relevant quoted products or derivatives – refer section 231 FMCA.
[5] Refer regulation 34 of the draft FMC Regulations, which is currently an empty bucket, to be filled by Registrar specifications.